DXCM earnings call for the period ending March 31, 2019.
News & Analysis: DexCom
Find out why our team of healthcare experts is laser-focused on these diabetes stocks right now.
The Internet of Things is already made up of billions of connected devices and is only expected to exponentially grow in the years ahead. Here's how investors can profit from the trend driving the smart home and industrial revolution.
Medical device stocks were hot in 2018. Here's which ones could sizzle in 2019.
Worry over growing competition caused investors to sell shares in this leading diabetes management company, but that could be a mistake.
The stock falls hard after a short-seller takes aim at the company.
Keep your eyes on these three hot diabetes stocks this month.
The diabetes-focused darling has been a monster winner. Is it too late to get in?
DXCM earnings call for the period ending December 31, 2018.
The company's preliminary 2018 results are sparking investor interest.